{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T11:41:11Z","timestamp":1720611671205},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011710","name":"Shaanxi Province Department of Science and Technology","doi-asserted-by":"publisher","award":["2014K11-01-01-20"],"id":[{"id":"10.13039\/501100011710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.compbiolchem.2021.107603","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T17:02:15Z","timestamp":1638205335000},"page":"107603","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Integrative bioinformatics analysis the clinical value of KMT5A in different subtypes of lung cancer"],"prefix":"10.1016","volume":"96","author":[{"given":"Shanshan","family":"Liu","sequence":"first","affiliation":[]},{"given":"Wenjuan","family":"Tian","sequence":"additional","affiliation":[]},{"given":"Burong","family":"Li","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.compbiolchem.2021.107603_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.3564","article-title":"Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas","volume":"48","author":"Campbell","year":"2016","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.compbiolchem.2021.107603_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.21149\/10115","article-title":"Squamous cell lung cancer: genomic evolution and personalized therapy","volume":"61","author":"Cardona","year":"2019","journal-title":"Salud Publica Mex."},{"key":"10.1016\/j.compbiolchem.2021.107603_bib3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.biopha.2016.12.007","article-title":"miR-382 inhibits tumor progression by targeting SETD8 in non-small cell lung cancer","volume":"86","author":"Chen","year":"2017","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.compbiolchem.2021.107603_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2016.12.038","article-title":"Monomethy-ltransferase SETD8 regulates breast cancer metabolism via stabilizing hypoxia-inducible factor 1\u03b1","volume":"390","author":"Huang","year":"2017","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.compbiolchem.2021.107603_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.compbiolchem.2021.107603_bib6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.molmed.2019.07.007","article-title":"Applications of CRISPR\/Cas9 technology in the treatment of lung cancer","volume":"25","author":"Jiang","year":"2019","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.compbiolchem.2021.107603_bib7","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1038\/s41467-018-05790-5","article-title":"BCL11A interacts with SOX2 to control the expression of epigenetic regulators in lung squamous carcinoma","volume":"9","author":"Lazarus","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.compbiolchem.2021.107603_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cllc.2014.09.004","article-title":"Comparative effectiveness of first-line platinum-based chemotherapy regimens for advanced lung squamous cell carcinoma","volume":"16","author":"Liao","year":"2015","journal-title":"Clin. Lung Cancer"},{"issue":"6","key":"10.1016\/j.compbiolchem.2021.107603_bib9","first-page":"4907","article-title":"KMT5A promotes metastasis of clear cell renal cell carcinoma through reducing cadherin-1 expression","volume":"17","author":"Lin","year":"2019","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.compbiolchem.2021.107603_bib10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3892\/mco.2014.311","article-title":"A meta-analysis of randomized controlled trials comparing early and late concurrent thoracic radiotherapy with etoposide and cisplatin\/carboplatin chemotherapy for limited-disease small-cell lung cancer","volume":"2","author":"Lu","year":"2014","journal-title":"Mol. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.compbiolchem.2021.107603_bib11","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.jtho.2018.07.006","article-title":"Nedaplatin plus docetaxel versus cisplatin plus docetaxel as first-line chemotherapy for advanced squamous cell carcinoma of the lung - a multicenter, open-label, randomized, phase iii trial","volume":"13","author":"Lu","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.compbiolchem.2021.107603_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106797","article-title":"Comprehensive analysis of the prognostic value and immune function of chemokine-CXC receptor family members in breast cancer","volume":"87","author":"Lyu","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"12","key":"10.1016\/j.compbiolchem.2021.107603_bib13","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1039\/C4MD00317A","article-title":"Structure-activity relationship studies of SETD8 inhibitors","volume":"5","author":"Ma","year":"2014","journal-title":"Medchemcomm"},{"issue":"1","key":"10.1016\/j.compbiolchem.2021.107603_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13073-018-0522-9","article-title":"Weak sharing of genetic association signals in three lung cancer subtypes: evidence at the SNP, gene, regulation, and pathway levels","volume":"10","author":"O\u2019Brien","year":"2018","journal-title":"Genome Med."},{"issue":"5","key":"10.1016\/j.compbiolchem.2021.107603_bib15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2796.2011.02427.x","article-title":"The Human Protein Atlas as a proteomic resource for biomarker discovery","volume":"270","author":"Ponten","year":"2011","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.compbiolchem.2021.107603_bib16","first-page":"31","article-title":"Danger matrix molecules orchestrate CD14\/CD44 signaling in cancer development","volume":"2019","author":"Roedig","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.compbiolchem.2021.107603_bib17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/acel.12607","article-title":"The PPARgamma-SETD8 axis constitutes an epigenetic, p53-independent checkpoint on p21-mediated cellular senescence","volume":"16","author":"Shih","year":"2017","journal-title":"Aging Cell"},{"issue":"16","key":"10.1016\/j.compbiolchem.2021.107603_bib18","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S1470-2045(15)00305-8","article-title":"Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial","volume":"16","author":"Shukuya","year":"2015","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.compbiolchem.2021.107603_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA\u00a0A Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.compbiolchem.2021.107603_bib20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41568-019-0179-8","article-title":"Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy","volume":"19","author":"Skoulidis","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"17","key":"10.1016\/j.compbiolchem.2021.107603_bib21","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1200\/JCO.2011.39.5848","article-title":"Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial","volume":"30","author":"Socinski","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.compbiolchem.2021.107603_bib22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccm.2011.08.005","article-title":"Pathology of lung cancer","volume":"32","author":"Travis","year":"2011","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.compbiolchem.2021.107603_bib23","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.2147\/OTT.S198998","article-title":"Identification of seven-gene signature for prediction of lung squamous cell carcinoma","volume":"12","author":"Wang","year":"2019","journal-title":"OncoTargets Ther."},{"issue":"10","key":"10.1016\/j.compbiolchem.2021.107603_bib24","article-title":"Genetic variation in a microRNA-502 minding site in SET8 gene confers clinical outcome of non-small cell lung cancer in a Chinese population","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.compbiolchem.2021.107603_bib25","first-page":"711","article-title":"Loss of miR-217 promotes osteosarcoma cell proliferation through targeting SETD8","volume":"73","author":"Yang","year":"2018","journal-title":"Pharmazie"},{"key":"10.1016\/j.compbiolchem.2021.107603_bib26","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1186\/1471-2407-14-684","article-title":"A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung","volume":"14","author":"Yang","year":"2014","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.compbiolchem.2021.107603_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/abbs\/gmt138","article-title":"Association of miR-502-binding site single nucleotide polymorphism in the 3\u2019-untranslated region of SET8 and TP53 codon 72 polymorphism with non-small cell lung cancer in Chinese population","volume":"46","author":"Yang","year":"2014","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"2","key":"10.1016\/j.compbiolchem.2021.107603_bib28","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.bbrc.2018.06.104","article-title":"mir-127-3p inhibits the proliferation of myocytes by targeting KMT5a","volume":"503","author":"Yuan","year":"2018","journal-title":"Biochem Biophys. Res. Commun."}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927121001730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927121001730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T11:57:58Z","timestamp":1642507078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927121001730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":28,"alternative-id":["S1476927121001730"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2021.107603","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrative bioinformatics analysis the clinical value of KMT5A in different subtypes of lung cancer","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2021.107603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107603"}}